Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma
Status:
Recruiting
Trial end date:
2023-01-20
Target enrollment:
Participant gender:
Summary
This clinical trial measures the amount and effect of lidocaine injected into patients with
glioblastoma while they are undergoing surgical removal of their brain tumors. Lidocaine is a
substance used to relieve pain by blocking signals at the nerve endings in skin. Information
gained from this study may help researchers come up with new treatments to help patients with
glioblastomas in the future.